US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.785
  • +0.044+5.88%
Close Feb 14 16:00 ET
  • 0.805
  • +0.020+2.56%
Post 19:46 ET
283.74MMarket Cap-1.06P/E (TTM)

About Lexicon Pharmaceuticals Company

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Company Profile

SymbolLXRX
Company NameLexicon Pharmaceuticals
Listing DateApr 7, 2000
Issue Price22.00
Founded1995
CEODr. Michael Exton, PhD
MarketNASDAQ
Employees285
Fiscal Year Ends12-31
Address2445 Technology Forest Boulevard,11th floor
CityThe Woodlands
ProvinceTexas
CountryUnited States of America
Zip Code77381-1160
Phone1-281-863-3000
Websitehttp://www.lexpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Exton, PhD
  • Chief Executive Officer and Director
  • --
  • Thomas A. Garner
  • Senior Vice President and Chief Commercial Officer
  • --
  • Scott M. Coiante
  • Senior Vice President and Chief Financial Officer
  • --
  • Dr. Craig B. Granowitz, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.53M
  • Kristen L. Alexander
  • Vice President, Finance and Accounting and Principal Accounting Officer
  • --
  • Dr. Kenneth B. Kassler-Taub, M.D.
  • Senior Vice President, Regulatory and Quality Assurance
  • --
  • Brian T. Crum
  • Senior Vice President and General Counsel
  • 1.42M
  • Dr. Alan J. Main,PhD
  • Executive Vice President, Innovation and Chemical Sciences
  • 1.39M
  • Wendy E. McDermott
  • Vice President, Human Resources
  • --
  • Raymond Debbane
  • Non-Executive Chairman of the Board
  • 127.82K
  • Ivan H. Cheung
  • Director
  • --
  • Dr. Judith L. Swain,M.D.
  • Independent Director
  • 104.96K
  • Dr. Samuel L. Barker,PhD
  • Independent Director
  • 117.46K
  • Diane E. Sullivan
  • Independent Director
  • 176.42K
  • Christopher J. Sobecki
  • Independent Director
  • 89.96K
  • Philippe J. Amouyal
  • Independent Director
  • 100.52K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!